University of Washington
Seattle, Washington, United States
Purpose
to define the qualities of an HIV vaccine that will make it sufficiently immunogenic to elicit protective responses in humans
Division
Global Health
Date
June 2006
Region Served
AFRICA, AMERICA, ASIA
Committed amount
$9,990,782
Grant topic
HIV
Duration (months)
66
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.